WASHINGTON, May 23 -- Aurinia Pharmaceuticals Inc. (AUPH), Edmonton, A0, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest held by Director R. Hector Mackay-dunn, Edmonton.
On May 21 the action involved disposition of 5630 Common Stocks. Mackay-dunn owns 18595 Common Stocks directly.
Disclaimer: Curated by HT Syndication....